Logo
Brain Frontier
About
Newsletter
Archive
Contact Us
Subscribe
background

BrainFrontier

Cutting-Edge Neuroscience & Psychedelic Insights—Curated by AI, Trusted by Humans

Peter Rock
Peter Rock
Feb 8, 2025

THE LATEST

BrainFrontier

Feb 8, 2025

MDMA Therapy Breakthrough: FDA Approval Nears After 71% PTSD Recovery Rate - B

Mar 5, 2025

MDMA Therapy Breakthrough: FDA Approval Nears After 71% PTSD Recovery Rate - C

Mar 5, 2025

MDMA-Assisted Therapy for PTSD Nears FDA Approval After Phase 3 Triumph

Feb 8, 2025

MDMA Therapy Breakthrough: FDA Approval Nears After 71% PTSD Recovery Rate - A

Mar 5, 2025

TRENDING POSTS

BrainFrontier

BrainFrontier

Cutting-Edge Neuroscience & Psychedelic Insights—Curated by AI, Trusted by Humans

Feb 8, 2025
MDMA Therapy Breakthrough: FDA Approval Nears After 71% PTSD Recovery Rate - D

MDMA Therapy Breakthrough: FDA Approval Nears After 71% PTSD Recovery Rate - D

Part 4 --> What the imminent FDA approval means for patients, clinicians, researchers, and the emerging psychedelic medicine industry

Mar 5, 2025
MDMA-Assisted Therapy for PTSD Nears FDA Approval After Phase 3 Triumph

MDMA-Assisted Therapy for PTSD Nears FDA Approval After Phase 3 Triumph

Building the base

Feb 8, 2025

ARCHIVES

BrainFrontier

BrainFrontier

Feb 8, 2025
BrainFrontier

BrainFrontier

Feb 8, 2025
MDMA Therapy Breakthrough: FDA Approval Nears After 71% PTSD Recovery Rate - B

MDMA Therapy Breakthrough: FDA Approval Nears After 71% PTSD Recovery Rate - B

Mar 5, 2025
MDMA Therapy Breakthrough: FDA Approval Nears After 71% PTSD Recovery Rate - C

MDMA Therapy Breakthrough: FDA Approval Nears After 71% PTSD Recovery Rate - C

Mar 5, 2025
MDMA-Assisted Therapy for PTSD Nears FDA Approval After Phase 3 Triumph

MDMA-Assisted Therapy for PTSD Nears FDA Approval After Phase 3 Triumph

Feb 8, 2025

Join our Newsletter 😄

Brain Frontier keeps you ahead of the next big discovery—without spending hours combing through dense papers.

ARCHIVES

BrainFrontier

BrainFrontier

Feb 8, 2025
MDMA Therapy Breakthrough: FDA Approval Nears After 71% PTSD Recovery Rate - B

MDMA Therapy Breakthrough: FDA Approval Nears After 71% PTSD Recovery Rate - B

Mar 5, 2025
MDMA Therapy Breakthrough: FDA Approval Nears After 71% PTSD Recovery Rate - C

MDMA Therapy Breakthrough: FDA Approval Nears After 71% PTSD Recovery Rate - C

Mar 5, 2025

TRENDING POSTS

BrainFrontier

BrainFrontier

Feb 8, 2025
MDMA-Assisted Therapy for PTSD Nears FDA Approval After Phase 3 Triumph

MDMA-Assisted Therapy for PTSD Nears FDA Approval After Phase 3 Triumph

Feb 8, 2025
MDMA Therapy Breakthrough: FDA Approval Nears After 71% PTSD Recovery Rate - C

MDMA Therapy Breakthrough: FDA Approval Nears After 71% PTSD Recovery Rate - C

Mar 5, 2025

LATEST POSTS

BrainFrontier

BrainFrontier

Feb 8, 2025
MDMA Therapy Breakthrough: FDA Approval Nears After 71% PTSD Recovery Rate - D

MDMA Therapy Breakthrough: FDA Approval Nears After 71% PTSD Recovery Rate - D

Mar 5, 2025

Brain Frontier keeps you ahead

Our Socials

Brain Frontier

“BrainFrontier is an AI-driven newsletter that cuts through the noise in neuroscience and psychedelic research. We track breakthrough studies, clinical trials, and market trends—and distill them into simple, actionable insights. Whether you’re an investor, a clinician, or just fascinated by the cutting edge of brain science, BrainFrontier keeps you ahead of the next big discovery—without spending hours combing through dense papers.”

Links

Home

About

Newsletter

Archives

Subscribe

Socials

Discord

Instagram

Youtube

Media

Podcast

Articles

© 2025 Brain Frontier.

Privacy policy

Terms of use

Powered by beehiiv